Effect of Restriction of Foods with High Fructose Corn Syrup Content on Metabolic Indices and Fatty Liver in Obese Children

Obesity Facts

Volumn 10, Issue 4, 2017, Pages 332-340

  Ibarra Reynoso, Lorena Del Rocio ^a   López Lemus, Hilda Lissette ^a   Garay Sevilla, Ma Eugenia ^a   Malacara, Juan Manuel ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Fructose; Hepatic steatosis; Obesity

Indexed keywords

CORN SYRUP; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; RETINOL BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL; FRUCTOSE;

ARTICLE; CHILD; CHILDHOOD OBESITY; DIET RESTRICTION; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STEATOSIS; TRIACYLGLYCEROL LEVEL; ADMINISTRATION AND DOSAGE; BLOOD; BLOOD PRESSURE; BODY MASS; BODY WEIGHT LOSS; CALORIC INTAKE; CARBOHYDRATE DIET; COMPLICATION; DIET THERAPY; INSULIN RESISTANCE;

BLOOD PRESSURE; BODY MASS INDEX; CHILD; DIETARY CARBOHYDRATES; ENERGY INTAKE; FATTY LIVER; FEMALE; FRUCTOSE; HIGH FRUCTOSE CORN SYRUP; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; PEDIATRIC OBESITY; TRIGLYCERIDES; WEIGHT LOSS;

EID: 85027162279     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000476069     Document Type: Article

References (45)

1. Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537-543.
2. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334.
3. Stanhope KL, Havel PJ: Fructose consumption: Potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008;19:16-24.
4. Jin R, Le NA, Liu S, Farkas Epperson M, Ziegler TR, Welsh JA, Jones DP, McClain CJ, Vos MB: Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab 2012;97:E1088-1098.
5. Brown CM, Dulloo AG, Yepuri G, Montani JP: Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008;294:730-737.
6. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer, Maier KP, Bischoff SC, Bergheim I: Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-1455.
7. Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Bantle JP, Johnson RJ, Diehl AM, Clark JM: Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012;56:952-960.
8. Neuschwander-Tetri BA: Carbohydrate intake and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2013;16:446-452.
9. Lonardo A, Bellentani S, Ratziu V, Loria P: Insulin resistance in non-alcoholicsteatohepatitis: Necessary but not sufficient-death of a dogma from analysis of therapeutic studies Expert Rev Gastroenterol Hepatol 2011;5:279-289.
10. Goyal NP, Schwimmer JB: The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2016;20:325-338.
11. Schwimmer J, Deutsch R, Kahen T, Lavine J, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393.
12. Kotronen A, Lewitt M, Hall K, Brismar K, Yki-Jarvinen H: Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. J Clin Endocrinol Metab 2008;93:4867-4872.
13. Clark JM, Diehl AM: Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2002;2:210-215.
14. Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, Chiumello G, Luzi L: Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006;291:697-703.
15. Crespo M, Lappe S, Feldstein AE, Alkhouri N: Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Metabolism 2016;65:1161-1171.
16. Kleiner DE, Makhlouf HR: Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis 2016;20:293-312.
17. Mencin AA, Loomba R, Lavine JE: Caring for children with NAFLD and navigating their care into adulthood. Nat Rev Gastroenterol Hepatol 2015;12:617-628.
18. Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Pérez O, Vázquez A, Ruiz A, Lanaspa MA, Jimenez CR, Johnson RJ, Lozada LG: The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: A randomized controlled trial. Metabolism 2011;60:1551-1559.
19. Madero M, Rodríguez Castellanos FE, Jalal D, Villalobos-Martín M, Salazar J, Vazquez-Rangel A, Johnson RJ, Sánchez-Lozada LG: A pilot study on the impact of a low fructose diet and allopurinol on clinic blood pressure among overweight and prehypertensive subjects: A randomized placebo controlled trial. J Am Soc Hypertens 2015;9:837-844.
20. Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz J-M: Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring) 2016;24:453-460.
21. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000;320:1240-1243.
22. National Health and Nutrition Examination Survey: Anthropometry Procedures Manual. 2007. www.cdc.gov/nchs/data/nhanes/bm.pdf (last accessed July 25, 2017).
23. Kurtoǧlu S, Hatipoǧlu N, Mazlcloǧlu M, Kendirici M, Keskin M, Kondolot M: Insulin resistance in obese children and adolescents: Homa-ir cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010;2:100-106.
24. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ: Utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
25. Mittelstaedt C: General Ultrasound. New York, Churchill Livingstone, 1992.
26. Matthews RH, Pehrsson PR, Farhat M: Sugar Content of Selected Foods: Individual and Total Sugars. Washington, D.C, United States Department of Agriculture, 1987.
27. Hernández JE, González L, Rosales E: Sistema de Evaluación de Hábitos Nutricionales y Consumo de Nutrimentos. SNUT. Instituto Nacional de Salud Pública. Centro de Investigación en Salud Poblacional. www.insp.mx/snut2003/(last accessed July 25, 2017).
28. Morgan RE: Does consumption of high-fructose corn syrup beverages cause obesity in children Pediatr Obes 2013;8:249-254.
29. Tamam S, Bellissimo N, Patel BP, Thomas SG, Anderson GH: Overweight and obese boys reduce food intake in response to a glucose drink but fail to increase intake in response to exercise of short duration. Appl Physiol Nutr Metab 2012;37:520-529.
30. André C. Carpentier. Acute adaptation of energy expenditure predicts diet-induced weight loss: Revisiting the thrifty phenotype. Diabetes 2015;64:2714-2716.
31. Ghosh S, Dent R, Harper ME, Stuart J, McPherson R: Blood gene expression reveal pathway differences between diet-sensitive and resistant obese subjects prior to caloric restriction. Obesity (Silver Spring) 2011;19:457-463.
32. Westerterp KR: Control of energy expenditure in humans. Eur J Clin Nutr 2017;71:340-344.
33. Rosenbaum M, Knight R, Leibel RL: The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 2015;26:493-501.
34. Te Morenga L, Mallard S, Mann J: Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012;346:e7492.
35. Goran MI, Walker R, Allayee H: Genetic-related and carbohydrate-related factors affecting liver fat accumulation. Curr Opin Clin Nutr Metab Care 2012;15:392-396.
36. Thompson FE, McNeel TS, Dowling EC, Midthune D, Morrissette M, Zeruto CA: Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc 2009;109:1376-1383.
37. Hernández-Riós R, Hernández-Estrada S, Cruz-Robles D, Hernández-Lobato S, Villalobos-Martín M, Johnson RJ, Rodríguez-Castellanos F, Salazar J, Garciá-Arroyo F, Sánchez-Lozada LG, Madero M: Low fructose and low salt diets increase mitochondrial DNA in white blood cells of overweight subjects. Exp Clin Endocrinol Diabetes 2013;121:535-538.
38. Campos V, Despland C, Brandejsky V, Kreis R, Schneiter P, Chiolero A, Boesch C, Tappy L: Sugar-and artificially sweetened beverages and intrahepatic fat: A randomized controlled trial. Obesity (Silver Spring) 2015;23:2335-2339.
39. Jin R, Le NA, Cleeton R, Sun X, Cruz Munõs J, Otvos J, Vos MB: Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids Health Dis 2015;14:39.
40. Ibarra-Reynoso LR, Pisarchyk L, Pérez-Luque EL, Garay-Sevilla ME, Malacara JM: Whole body and hepatic insulin resistance in obese children. PLoS One 2014;9:e113576.
41. Kleiner DE, Makhlouf HR: Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis 2016;20:293-312.
42. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR: Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-129.
43. Volynets V, Machann J, Küper MA, Maier IB, Spruss A, Königsrainer A, Bischoff SC, Bergheim I: A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): A pilot study. Eur J Nutr 2013;52:527-535.
44. Siejka A, Jankiewicz-Wika J, Kołomecki K, Cywiński J, Piestrzeniewicz K, Swiȩtosławski J, Stepien H, Komorowski J: Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. Cytokine 2013;64:490-493.
45. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF: Serum leptin in children with obesity: Relationship to gender and development. Pediatrics 1996;98:201-203.